Adam Kaczorowski

2.8k total citations · 1 hit paper
27 papers, 2.1k citations indexed

About

Adam Kaczorowski is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Adam Kaczorowski has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Adam Kaczorowski's work include Renal cell carcinoma treatment (11 papers), Renal and related cancers (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Adam Kaczorowski is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Renal and related cancers (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Adam Kaczorowski collaborates with scholars based in Germany, United States and China. Adam Kaczorowski's co-authors include Piero Dalerba, Mark E. Prince, Gregory T. Wolf, Irving L. Weissman, Ranjiv Sivanandan, Laurie Ailles, Michael J. Kaplan, Michael F. Clarke, Kamesh R. Babu and Mahesh Appari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Adam Kaczorowski

24 papers receiving 2.1k citations

Hit Papers

Identification of a subpopulation of cells with cancer st... 2007 2026 2013 2019 2007 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Kaczorowski Germany 9 1.4k 1.2k 655 237 179 27 2.1k
Zeshaan A. Rasheed United States 23 1.7k 1.2× 1.3k 1.1× 658 1.0× 190 0.8× 211 1.2× 40 2.4k
Hyejin Choi United States 11 1.2k 0.9× 1.3k 1.1× 837 1.3× 238 1.0× 269 1.5× 19 2.2k
Marjan Iravani United Kingdom 22 853 0.6× 1.1k 1.0× 812 1.2× 169 0.7× 250 1.4× 34 2.1k
Pallavi Chaturvedi United States 15 923 0.6× 1.5k 1.3× 1.0k 1.5× 175 0.7× 192 1.1× 24 2.4k
Xiaofeng Zheng United States 22 1.6k 1.1× 1.7k 1.4× 917 1.4× 272 1.1× 300 1.7× 52 2.9k
Federica Francescangeli Italy 23 711 0.5× 981 0.9× 648 1.0× 194 0.8× 147 0.8× 40 1.6k
Giulia Bertolini Italy 17 989 0.7× 753 0.7× 504 0.8× 113 0.5× 221 1.2× 42 1.6k
Yoshimi Arima Japan 27 906 0.6× 1.2k 1.0× 396 0.6× 297 1.3× 291 1.6× 46 2.0k
Anne C. Pavlick United States 17 1.8k 1.3× 1.2k 1.0× 641 1.0× 125 0.5× 268 1.5× 57 2.4k
Ethan V. Abel United States 22 1.3k 0.9× 1.7k 1.5× 430 0.7× 218 0.9× 113 0.6× 30 2.3k

Countries citing papers authored by Adam Kaczorowski

Since Specialization
Citations

This map shows the geographic impact of Adam Kaczorowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Kaczorowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Kaczorowski more than expected).

Fields of papers citing papers by Adam Kaczorowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Kaczorowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Kaczorowski. The network helps show where Adam Kaczorowski may publish in the future.

Co-authorship network of co-authors of Adam Kaczorowski

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Kaczorowski. A scholar is included among the top collaborators of Adam Kaczorowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Kaczorowski. Adam Kaczorowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tosev, Georgi, Adam Kaczorowski, Constantin Schwab, et al.. (2024). PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study. Diagnostics. 14(7). 741–741.
2.
Kaczorowski, Adam, Cathleen Nientiedt, Constantin Schwab, et al.. (2024). Deficiency in DNA Damage Repair Proteins Promotes Prostate Cancer Cell Migration through Oxidative Stress. SHILAP Revista de lepidopterología. 4(2). 56–67. 1 indexed citations
3.
Kaczorowski, Adam, F Schneider, Angela Sun, et al.. (2024). Immune landscape of renal cell carcinoma with metastasis to the pancreas. Urologic Oncology Seminars and Original Investigations. 42(11). 373.e9–373.e17. 1 indexed citations
4.
Schneider, F, Huancai Lin, Adam Kaczorowski, et al.. (2024). Region of interest localization, tissue storage time, and antibody binding density—a technical note on the GeoMx® Digital Spatial Profiler. Immuno-Oncology Technology. 23. 100727–100727.
5.
Schütz, Viktoria, Huancai Lin, Adam Kaczorowski, et al.. (2023). Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma. Cancers. 15(24). 5715–5715. 2 indexed citations
6.
Schwarz, Sebastian, Cathleen Nientiedt, Elena‐Sophie Prigge, et al.. (2023). Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer. Pathobiology. 90(5). 312–321. 4 indexed citations
7.
Schneider, F, Adam Kaczorowski, Martina Kirchner, et al.. (2023). Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma. Cancers. 15(20). 5050–5050. 6 indexed citations
8.
Nientiedt, Cathleen, Adam Kaczorowski, Stefanie Zschäbitz, et al.. (2022). Interleukin-2 and Interferon-α for Advanced Renal Cell Carcinoma: Patient Outcomes, Sexual Dimorphism of Responses, and Multimodal Treatment Approaches over a 30-Year Period. Urologia Internationalis. 106(11). 1158–1167. 8 indexed citations
9.
Schneider, F, et al.. (2022). Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities. Frontiers in Oncology. 12. 889686–889686. 3 indexed citations
10.
Sun, Angela, Lijun Liu, Aparna Rao, et al.. (2022). Targeting the translational machinery in gastrointestinal stromal tumors (GIST): a new therapeutic vulnerability. Scientific Reports. 12(1). 8275–8275. 4 indexed citations
11.
Heckmann-Nötzel, Doreen, Adam Kaczorowski, Markus Hohenfellner, et al.. (2021). miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells. Cancers. 13(5). 964–964. 8 indexed citations
12.
Tosev, Georgi, Wasilijiang Wahafu, Constantin Schwab, et al.. (2021). Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder. Scientific Reports. 11(1). 14244–14244. 15 indexed citations
13.
Tosev, Georgi, Wasilijiang Wahafu, Constantin Schwab, et al.. (2021). Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder. Scientific Reports. 11(1). 18358–18358. 2 indexed citations
14.
Gau, David, Paul Francoeur, Yue Wang, et al.. (2020). Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells. Journal of Biological Chemistry. 295(46). 15636–15649. 17 indexed citations
15.
Kaczorowski, Adam, Yanis Tolstov, Michael Falkenstein, et al.. (2020). Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53. Urologic Oncology Seminars and Original Investigations. 38(9). 736.e1–736.e10. 4 indexed citations
17.
Kaczorowski, Adam, Xin Chen, Esther Herpel, et al.. (2020). Antibody selection influences the detection of AR-V7 in primary prostate cancer. Cancer Treatment and Research Communications. 24. 100186–100186. 5 indexed citations
18.
Falkenstein, Michael, Adam Kaczorowski, Yanis Tolstov, et al.. (2018). FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer. Urologic Oncology Seminars and Original Investigations. 36(8). 365.e15–365.e26. 16 indexed citations
19.
Appari, Mahesh, et al.. (2014). Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition. International Journal of Oncology. 45(4). 1391–1400. 117 indexed citations
20.
Rausch, Vanessa, Li Liu, Anja Apel, et al.. (2012). Autophagy mediates survival of pancreatic tumour‐initiating cells in a hypoxic microenvironment. The Journal of Pathology. 227(3). 325–335. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026